Professor Shlomo Ben-Haim, a renowned medical device entrepreneur, has an impressive record of co-founding companies and maximizing their value. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics at both Harvard University and the Technion – Israel Institute of Technology. Professor Ben-Haim’s education was in Medicine and Biophysics. He has published over 200 scientific papers in peer-reviewed journals, and is the recipient of a long list of prizes for his research and inventions. Professor Ben-Haim is the inventor of more than 550 patents and patent applications worldwide, including those for a navigated cardiac catheterization system and an implantable device for treating congestive heart failure and diabetes. Professor Ben-Haim is now focusing on building businesses in healthcare that improve patient health, and reduce total healthcare spending.
Mr. Chan is the Investment Director of Henderson (China) Investment Ltd, and has 14 years of experience in Asset Management, M&A, Venture Capital and Private Equity. So far, Mr. Chan managed over US$1 billion of investment. Prior to joining Henderson, he worked as Senior Vice President and Head of Private Equity for CCB International and CMS Capital respectively. Mr. Chan holds a Bachelor’s degree in Finance and Economics from The University of Melbourne and a Master’s degree in Applied Finance from The Monash University (Melbourne).
Fred Hrkac is a 22 year veteran in the medical device industry, having worked 15 years with Johnson & Johnson in the start-up of the Central Eastern Europe operations, and as Vice President International for the Biosense Webster division. Most recently he was President of Boston Scientific, Europe, Middle East and Africa running a $2 billion P&L. Fred has spent 11 years in Electrophysiology/CRM working in Boston Scientific, Sorin CRM and Biosense Webster.
A senior executive with 35 years’ experience of the international medical devices industry, 15 years of which have been at Board level. For the past 11 years he has been President at Biosensors International, two years as CEO where Biosensors has grown from a start-up to become the fourth largest supplier of cardiac stents in the world. In addition to his roles at Biosensors he has served as a Non-Executive Director on the Board of various medical device companies including PneumRx, Veryan Medical, Maya, Benechill, Anecova and ARTS. He was chairman of Biosensors Europe and served on the board of Biosensors International, as well as Biosensors Singapore, India, France, Japan, Germany, Spain, and Brazil. Jeff is currently Chairman of MedAlliance SA, Chairman of Manli Cardiology, and an independent board member for Veryan, Symetis and Impulse Dynamics.
Dr. Simos Kedikoglou is the CEO of Impulse Dynamics since 2013 and serves on the Company’s Board of Directors. He was previously CEO of MedInvest, an Israeli Medical Technology Incubator overseeing 10 portfolio companies with responsibility for their clinical and commercial strategy, technology development and debt and equity financing. He has also served as Corporate Vice President of Business Development for Boston Scientific responsible for acquisitions, licensing and distribution deals in the US, Europe and Asia and an Associate Partner with McKinsey & Company in the US advising clients on acquisitions in pharmaceuticals and medical devices. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction from Harvard Business School as well as a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.
Mr. Owers joined Impulse Dynamics N.V. in 2001 and is responsible for all aspects of the Curaçao-based Company. He was with the accounting firm KPMG from 1969-98 in London, São Paulo, Brazil and Curaçao, the latter as a Senior Partner for many years. He has been a Fellow of the Institute of Chartered Accountants in England and Wales since 1980, and has been British consul to the Dutch Caribbean islands since 1997. He is also treasurer of many charitable foundations in the Netherlands Antilles including the Red Cross, International School, National Trust, Consular Corps, Rotary and Uniting for Children.
Dan has been with Teva since 1976. He has been Chief Financial Officer from 1978 to 2008 and is still a member of the Board. From 1970 until 1976 he was a Consultant and Securities Analyst with International Consultants Ltd. He received his B.A. in Economics and Political Science from the Hebrew University in 1965 and an M.B.A. from the University of Massachusetts in 1969.
A cardiologist by profession, Dr. Suverkropp has been educated and trained in the Netherlands. He began his career as a Cardiologist in 1983, specializing in Electrophysiology and Pacemaker devices, and serving as Chief consultant of the Catharina Ziekenhuis in Eindhoven, the Netherlands. In 1993 he established a D.C. Cardiology Practice with a complete non-invasive cardiac laboratory in Curacao, where he currently serves as Managing Director. The practice serves the 3 local hospitals, but also patients from around the island province. Dr. Suverkropp has published several scientific publications in Cardiology, and has previously held faculty appointments as Assistant Professor of Cardiology at St.Martinus University and International Medical University of Saba.
Mr. Ray Yang joined CITIC in 2011 and is active in global investments. During his 8 years of experience, he has completed investments and realized exits in more than a dozen companies in both China and overseas; examples include United Imagining, Genomics and Impulse Dynamics. Mr. Yang holds a Bachelor of Engineering, Masters of Management Science and Engineering from Tsinghua University, China and also a Masters of Engineering from Aachen University, Germany.